Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.

Casey SP, Kemp WW, McLean CA, Topliss DJ, Adams LA, Roberts SK.

Scand J Gastroenterol. 2012 Jul;47(7):836-41. doi: 10.3109/00365521.2012.677955. Epub 2012 Apr 23.

PMID:
22519948
2.

Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.

Sobhonslidsuk A, Pulsombat A, Kaewdoung P, Petraksa S.

Asian Pac J Cancer Prev. 2015;16(5):1789-94.

3.

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M.

J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21.

PMID:
20932598
4.

Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.

Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, Nobili V.

Liver Int. 2013 Jan;33(1):79-85. doi: 10.1111/liv.12024. Epub 2012 Nov 12.

PMID:
23146095
5.

Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.

Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M.

Liver Int. 2010 Nov;30(10):1471-80. doi: 10.1111/j.1478-3231.2010.02331.x. Epub 2010 Aug 30.

PMID:
20807336
6.

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.

Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P, Elkashab M.

Liver Int. 2012 Jul;32(6):902-10. doi: 10.1111/j.1478-3231.2012.02781.x. Epub 2012 Mar 21.

PMID:
22435761
7.

Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis.

Sharma P, Dhawan S, Bansal R, Tyagi P, Bansal N, Singla V, Kumar A, Matin A, Arora A.

Indian J Gastroenterol. 2014 Sep;33(5):445-51. doi: 10.1007/s12664-014-0491-x. Epub 2014 Aug 21.

PMID:
25138787
8.

Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.

Doycheva I, Cui J, Nguyen P, Costa EA, Hooker J, Hofflich H, Bettencourt R, Brouha S, Sirlin CB, Loomba R.

Aliment Pharmacol Ther. 2016 Jan;43(1):83-95. doi: 10.1111/apt.13405. Epub 2015 Sep 15.

9.

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

Morling JR, Fallowfield JA, Guha IN, Nee LD, Glancy S, Williamson RM, Robertson CM, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study investigators.

J Hepatol. 2014 Feb;60(2):384-91. Epub 2013 Oct 26.

PMID:
24512822
10.

Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.

Wu FM, Opotowsky AR, Raza R, Harney S, Ukomadu C, Landzberg MJ, Valente AM, Breitbart RE, Singh MN, Gauvreau K, Jonas MM.

Congenit Heart Dis. 2014 Sep-Oct;9(5):438-47. doi: 10.1111/chd.12159. Epub 2014 Jan 13.

PMID:
24418160
11.

Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.

Lee HW, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Kim KJ, Han KH.

Dig Dis Sci. 2017 Aug;62(8):2150-2158. doi: 10.1007/s10620-017-4592-0. Epub 2017 May 18.

PMID:
28523578
12.

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis.

Chung JH, Ahn HS, Kim SG, Lee YN, Kim YS, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS.

Clin Mol Hepatol. 2013 Jun;19(2):156-64. doi: 10.3350/cmh.2013.19.2.156. Epub 2013 Jun 27.

13.

Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.

Mahadeva S, Mahfudz AS, Vijayanathan A, Goh KL, Kulenthran A, Cheah PL.

J Dig Dis. 2013 Nov;14(11):604-10. doi: 10.1111/1751-2980.12088.

PMID:
23859493
14.

Outreach screening of drug users for cirrhosis with transient elastography.

Moessner BK, Jørgensen TR, Skamling M, Vyberg M, Junker P, Pedersen C, Christensen PB.

Addiction. 2011 May;106(5):970-6. doi: 10.1111/j.1360-0443.2010.03246.x. Epub 2010 Dec 23. Erratum in: Addiction. 2012 Jan;107(1):236.

PMID:
21182552
15.

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.

Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, Sung JJ, de Lédinghen V.

Hepatology. 2010 Feb;51(2):454-62. doi: 10.1002/hep.23312.

PMID:
20101745
16.

Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.

Lupsor M, Badea R, Stefanescu H, Grigorescu M, Serban A, Radu C, Crişan D, Sparchez Z, Iancu S, Maniu A.

J Gastrointestin Liver Dis. 2010 Mar;19(1):53-60.

17.

Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years.

Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, Le Clesiau H, Beaugrand M.

Gut. 2011 Jul;60(7):977-84. doi: 10.1136/gut.2010.221382. Epub 2010 Nov 10.

PMID:
21068129
18.

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A.

Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.

19.

Liver Stiffness Evaluation by Transient Elastography in Type 2 Diabetes Mellitus Patients with Ultrasound-proven Steatosis.

Sporea I, Mare R, Lupușoru R, Sima A, Sirli R, Popescu A, Timar R.

J Gastrointestin Liver Dis. 2016 Jun;25(2):167-74. doi: 10.15403/jgld.2014.1121.252.lsf.

20.

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

Macaluso FS, Maida M, Cammà C, Cabibbo G, Cabibi D, Alduino R, Di Marco V, Craxì A, Petta S.

J Hepatol. 2014 Sep;61(3):523-9. doi: 10.1016/j.jhep.2014.04.045. Epub 2014 May 9.

PMID:
24815874

Supplemental Content

Support Center